Search results for "ECL"

showing 10 items of 1262 documents

Imaging photoplethysmography for clinical assessment of cutaneous microcirculation at two different depths

2016

The feasibility of bispectral imaging photoplethysmography (iPPG) system for clinical assessment of cutaneous microcirculation at two different depths is proposed. The iPPG system has been developed and evaluated for in vivo conditions during various tests: (1) topical application of vasodilatory liniment on the skin, (2) skin local heating, (3) arterial occlusion, and (4) regional anesthesia. The device has been validated by the measurements of a laser Doppler imager (LDI) as a reference. The hardware comprises four bispectral light sources (530 and 810 nm) for uniform illumination of skin, video camera, and the control unit for triggering of the system. The PPG signals were calculated and…

AdultPathologymedicine.medical_specialtyAdolescentBiomedical EngineeringLinimentHyperemiaCutaneous microcirculation02 engineering and technologyAdministration Cutaneous01 natural sciencesMicrocirculation010309 opticsBiomaterialsYoung AdultPhotoplethysmogram0103 physical sciencesImage Processing Computer-AssistedHumansMedicinePhotoplethysmographySkinbusiness.industryMicrocirculationEquipment DesignLaser Doppler velocimetryHand021001 nanoscience & nanotechnologyArterial occlusionAtomic and Molecular Physics and OpticsElectronic Optical and Magnetic Materials0210 nano-technologybusinessPerfusionPreclinical imagingAnesthesia LocalBiomedical engineeringJournal of Biomedical Optics
researchProduct

CD15 immunostaining improves placental diagnosis of fetal hypoxia

2020

Fetal hypoxic events with unclear predictive value are a common indication for placenta examination. We evaluated whether the use of CD15 immunostaining can improve the assessment of severity and duration of fetal hypoxia.We compared placentas (37-42 gestational weeks) from stillborns/newborns with birth asphyxia (BA) and non-hypoxic newborns. Placental findings were studied in following groups: (1) acute BA (n = 11) due to placental abruption, (2) non-acute BA (n = 121) due to non-acute conditions, (3) non-BA (n = 46) in pregnancies with preeclampsia and gestational diabetes, and (4) controls (n = 30).A high expression of CD15 in feto-placental resistance vessels (FRVs) was present in non-…

AdultPlacentaPlacental FindingLewis X AntigenIntrauterine hypoxiaFetal HypoxiaPreeclampsiaAndrologyPre-EclampsiaPregnancyPlacentaHumansMedicineRetrospective StudiesAsphyxiaFetusPlacental abruptionbusiness.industryInfant NewbornObstetrics and Gynecologymedicine.diseaseImmunohistochemistryGestational diabetesmedicine.anatomical_structureReproductive Medicineembryonic structuresFemalemedicine.symptombusinessDevelopmental BiologyPlacenta
researchProduct

The Maternal Cytokine and Chemokine Profile of Naturally Conceived Gestations Is Mainly Preserved duringIn VitroFertilization and Egg Donation Pregna…

2015

This prospective longitudinal study aimed at comparing maternal immune response among naturally conceived (NC;n=25),in vitrofertilization (IVF;n=25), and egg donation (ED;n=25) pregnancies. The main outcome measures were, firstly, to follow up plasma levels of interleukin (IL) 1beta, IL2, IL4, IL5, IL6, IL8, IL10, IL17, interferon gamma, tumor necrosis factor-alpha (TNFα), transforming growth factor-beta (TGFβ), regulated upon activation normal T-cell expressed and secreted (RANTES), stromal cell-derived factor 1 alpha (SDF1α), and decidual granulocyte-macrophage colony-stimulating factor (GM-CSF) during the three trimesters of pregnancy during the three trimesters of pregnancy; secondly, t…

AdultProteomicslcsh:Immunologic diseases. Allergymedicine.medical_specialtyChemokineArticle SubjectT-Lymphocytesmedicine.medical_treatmentImmunologyFertilization in VitroPreeclampsiaPregnancyInternal medicinemedicineCluster AnalysisHumansImmunology and AllergyLongitudinal StudiesProspective StudiesInterleukin 8Pregnancy TrimestersPregnancyIn vitro fertilisationbiologybusiness.industryImmunityPregnancy OutcomeGeneral Medicinemedicine.diseaseInterleukin 10Endocrinologybiology.proteinCytokinesGestationFemalePregnancy TrimestersChemokineslcsh:RC581-607businessBiomarkersResearch ArticleJournal of Immunology Research
researchProduct

Mass Output and Particle Size Distribution of Glucocorticosteroids Emitted from Different Inhalation Devices Depending on Various Inspiratory Paramet…

2002

Efficient inhalation therapy depends on successful delivery of the drug to the lung. The efficacy of drug delivery is not only influenced by the characteristics of the inhalation device, but also by the patient's handling of the device and by the inspiratory maneuver achieved through the device. We analyzed the output characteristics of three different chlorofluorocarbon (CFC)-free breath-actuated inhalers for inhaled glucocorticosteroids (BUD Turbohaler, FP Diskus/Accuhaler and HFA-BDP Autohaler, respectively). Mass output and particle size distribution of drug aerosol delivered by the inhalers were determined depending on different inhalation parameters in vitro using an Andersen cascade …

AdultPulmonary and Respiratory MedicineAnti-Inflammatory AgentsPulmonary Disease Chronic Obstructivechemistry.chemical_compoundAdministration InhalationHumansPharmacology (medical)Particle SizeBudesonideChildPeak flow meterLungmeasurement_unitAerosolsChlorofluorocarbonInhalationNebulizers and VaporizersInhalerBeclomethasoneAsthmaAerosolAndrostadienesInhalationchemistryVolume (thermodynamics)Anesthesiameasurement_unit.measuring_instrumentRespiratory MechanicsFluticasoneParticleParticle sizeBiomedical engineeringJournal of Aerosol Medicine
researchProduct

Antiphospholipid syndrome in obstetrics.

2003

Antiphospholipid syndrome (APLS) in pregnancy is characterized by the presence of autoantibodies in association with recurrent fetal loss and severe complications such as preeclampsia, fetal growth retardation, or placental insufficiency. The most clinically important serologic markers are lupus anticoagulant, anticardiolipin antibodies, and recently anti-beta-2-glycoprotein 1 antibodies. At present, standardization does not exist and a definitive association between specific clinical manifestation and antibody level is not yet known. Experimental data gave evidence that passive transfer of antiphospholipid antibodies result in clinical manifestation of APLS, that is, fetal loss and thromb…

Adultmedicine.medical_specialtyAbortion HabitualPlacental insufficiency030204 cardiovascular system & hematologyGastroenterologyPreeclampsia03 medical and health sciences0302 clinical medicinePre-Eclampsiaimmune system diseasesAntiphospholipid syndromePregnancyInternal medicinemedicinePrevalenceHumansThrombophiliaAnnexin A5030203 arthritis & rheumatologyLupus anticoagulantAspirinPregnancyFetal Growth RetardationAspirinbusiness.industryHeparinStandard treatmentInfant NewbornAnticoagulantsImmunoglobulins IntravenousHematologyGeneral MedicineHeparinmedicine.diseaseAntiphospholipid SyndromePlacental InsufficiencyThrombocytopeniaAbortion SpontaneousPregnancy ComplicationsAntibodies AnticardiolipinLupus Coagulation InhibitorImmunologyPrednisoneFemalebusinessImmunity Maternally-AcquiredImmunosuppressive Agentsmedicine.drugClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
researchProduct

The role of recent thymic emigrant-regulatory T-cell (RTE-Treg) differentiation during pregnancy.

2014

During pregnancy, regulatory T cells (Tregs) have a key role in maternal immune tolerance to the semi-allogeneic fetus. Our previous results showed that the naive CD45RA(+)-Treg pool is functionally improved in pregnant women compared with non-pregnant women. Therefore, we examined the thymic output and differentiation of CD45RA(+)CD31(+) recent thymic emigrant (RTE)-Tregs during normal pregnancy and in the presence of preeclampsia. With the onset of pregnancy, the composition of the total CD4(+)CD127(low+/-)FoxP3(+)-Treg pool changed in the way that its percentage of RTE- and CD45RA(-)CD31(+)-memory Tregs decreased strongly, whereas that of the CD45RA(+)CD31(-)-mature naive (MN)-Tregs did …

Adultmedicine.medical_specialtyAdolescentRegulatory T cellImmunologyRecent Thymic Emigrantchemical and pharmacologic phenomenaThymus GlandT-Lymphocytes RegulatoryPreeclampsiaImmune toleranceYoung AdultPre-EclampsiaPregnancyT-Lymphocyte SubsetsInternal medicineImmune ToleranceImmunology and AllergyMedicineAnimalsHumansInterleukin-7 receptorFetusPregnancybusiness.industryFOXP3hemic and immune systemsCell DifferentiationForkhead Transcription FactorsCell BiologyMiddle Agedmedicine.diseasemedicine.anatomical_structureEndocrinologyLeukocyte Common AntigensFemalebusinessImmunologic MemoryImmunology and cell biology
researchProduct

Mean maternal second-trimester hemoglobin concentration and outcome of pregnancy: a population-based study.

2008

Both anemia and the lack of physiological maternal plasma volume expansion during the second trimester are associated with higher maternal morbidity and poor fetal outcome. Mean hemoglobin levels between the 14th and 30th gestational weeks were calculated in 4985 consecutive pregnant women and were correlated with outcome data of pregnancy. It was found that 9.4% of participants (n = 3959) had normal pregnancy outcome. Mean maternal hemoglobin levels were significantly lower in women with a normal pregnancy (11.96 ± 0.94 g/dL) compared with women who had adverse outcome events (preeclampsia, n = 423, 12.5 ± 1.0 g/dL, P < .0001; early birth, n = 464, 12.2 ± 1.01 g/dL, P < .0001; low b…

Adultmedicine.medical_specialtyAnemiaPopulationMothersPreeclampsiaHemoglobinsPregnancymedicineHumansRisk factoreducationGynecologyeducation.field_of_studyPregnancybusiness.industryPregnancy OutcomeHematologyGeneral MedicineOdds ratiomedicine.diseaseConfidence intervalPregnancy ComplicationsLow birth weightPregnancy Trimester SecondWomen's HealthFemalemedicine.symptombusinessClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
researchProduct

Beclomethasone dipropionate hydrofluoroalkane for the treatment of allergic rhinitis

2016

Allergic rhinitis (AR) is a common respiratory disease, and its prevalence is increasing all over the world, both in adults and in children. Patients experience symptoms that may negatively impact on physical, social and psychological well-being. Hence, if left untreated, allergic rhinitis may significantly affect quality of life. Under current guidelines, intranasal corticosteroids are considered the most effective drugs and they are recommended as first-line therapy. Among the several corticosteroid intranasal sprays available, beclomethasone dipropionate is one of the most prescribed. Recently, new intranasal hydrofluoroalkane-propelled formulations with little or no impact on the ozone …

Adultmedicine.medical_specialtyHydrocarbons Fluorinatedintranasal corticosteroidmedicine.drug_classmedicine.medical_treatmentImmunologynasal sprayAnti-asthmatic AgentMedication Adherence03 medical and health sciencesnasal aerosol0302 clinical medicineQuality of lifeNasal AerosolmedicineAnimalsHumansImmunology and AllergyAnti-Asthmatic AgentsChild030223 otorhinolaryngologyintranasal corticosteroidsAsthmaallergic rhinitisbusiness.industryRespiratory diseaseBeclomethasoneNasal Spraysasthmamedicine.diseaseRhinitis AllergicDermatologyBeclomethasone dipropionate hydrofluoroalkaneAerosol Propellants030228 respiratory systemNasal sprayinflammationQuality of LifeCorticosteroidNasal administrationbusinessallergic rhiniti
researchProduct

Preeclampsia and gestational weight gain in the Norwegian Fit for Delivery trial

2018

Abstract Objective Excessive gestational weight gain is linked to risk of preeclampsia, but it is not clear whether the association is causal. The purpose of this paper was to examine gestational weight gain in the Norwegian Fit for Delivery study among women who developed preeclampsia compared to those who did not, and to further explore associations between weight gain and preeclampsia by including data on body composition (bioimpedance) assessed in the last trimester of pregnancy. Results A total of 550 women were eligible for the study. Women who developed preeclampsia gained more weight than women who did not (difference 3.7 kg, p = 0.004), with a 3.5 kg difference in total body water …

Adultmedicine.medical_specialtyRandomizationBody waterlcsh:MedicineGestational weight gainWeight GainBody compositionGeneral Biochemistry Genetics and Molecular BiologyPreeclampsia03 medical and health sciences0302 clinical medicinePre-EclampsiaPregnancymedicineHumans030212 general & internal medicinePrimiparalcsh:Science (General)lcsh:QH301-705.5Pregnancy030219 obstetrics & reproductive medicineFat massObstetricsbusiness.industryNorwaylcsh:RGeneral Medicinemedicine.diseaseDelivery ObstetricPreeclampsiaClinical trialResearch Notelcsh:Biology (General)GestationFemalemedicine.symptombusinessBody mass indexWeight gainlcsh:Q1-390BMC Research Notes
researchProduct

Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia

1991

In pregnancy a decrease in fibrinolytic activity, which is due to an increase in plasminogen activator inhibitor activity and plasminogen activator inhibitor type 1 and type 2, has been described. Because the placenta is a source of both type 1 and type 2 plasminogen activator inhibitor, we have studied them and other fibrinolytic parameters in a group of normotensive pregnant women with intrauterine fetal growth retardation and in two groups of women with preeclampsia, with or without intrauterine growth retardation. A significant increase in plasminogen activator inhibitor type 1 antigen and plasminogen activator inhibitor activity was observed in preeclampsia, with or without intrauterin…

Adultmedicine.medical_specialtymedicine.medical_treatmentBlood PressurePreeclampsiaPre-EclampsiaAntigenPregnancyReference ValuesInternal medicinePlacentaFibrinolysismedicineFetal growthHumansPregnancyFetal Growth Retardationbusiness.industryFibrinolysisObstetrics and Gynecologymedicine.diseaseUrokinase-Type Plasminogen ActivatorPathophysiologyPlasminogen Inactivatorsmedicine.anatomical_structureEndocrinologyTissue Plasminogen ActivatorImmunologyFemalebusinessPlasminogen activatorAmerican Journal of Obstetrics and Gynecology
researchProduct